Similar funds
Computed 2026-07-05Funds whose latest portfolio most overlaps this one — the share of this fund's holdings each peer reproduces, by weight. Click an overlap score for the side-by-side comparison.
| # | Fund | Overlap | Net exp. | Adviser |
|---|---|---|---|---|
| 1 | ProShares UltraShort Consumer Discretionary · SCC | 100% | 0.95% | PROSHARE ADVISORS LLC |
| 2 | ProShares UltraShort Technology · REW | 99% | 0.95% | PROSHARE ADVISORS LLC |
| 3 | ProShares Short Financials · SEF | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 4 | ProShares UltraShort MidCap400 · MZZ | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 5 | ProShares Short MidCap400 · MYY | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 6 | ProShares Short SmallCap600 · SBB | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 7 | ProShares Short Real Estate · REK | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 8 | ProShares UltraShort SmallCap600 · SDD | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 9 | ProShares UltraShort Materials · SMN | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 10 | ProShares UltraShort Consumer Staples · SZK | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 11 | ProShares UltraShort Industrials · SIJ | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 12 | ProShares UltraShort Utilities · SDP | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 13 | ProShares UltraShort Nasdaq Biotechnology · BIS | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 14 | ProShares UltraShort MSCI Emerging Markets · EEV | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 15 | ProShares UltraShort MSCI Japan · EWV | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 16 | ProShares UltraShort MSCI EAFE · EFU | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 17 | ProShares Short MSCI Emerging Markets · EUM | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 18 | ProShares Short MSCI EAFE · EFZ | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 19 | ProShares UltraShort MSCI Brazil Capped · BZQ | 98% | 0.95% | PROSHARE ADVISORS LLC |
| 20 | ProShares UltraShort FTSE Europe · EPV | 98% | 0.95% | PROSHARE ADVISORS LLC |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.